FDA Grants Market Clearance for Permaseal

July 29, 2016

Micro Interventional Devices received FDA clearance for the company’s first product, a transapical access and closure device.

The Permaseal device allows surgeons to access and close the left-ventricle fast and reliably without suturing the myocardium.

Clinical trial indicated that the device shortened operating time and hospitalization. — Cynthia Jessup

View today's stories